Biocompatible Photopolymer 3D Printing: System-Level Control of Conver

Polymer Conversion in Photopolymer 3D Printing

Why Conversion Alone Does Not Define Real Safety

A system-level technical interpretation of degree of conversion, residual species, extractables and workflow dependency in SLA, DLP and LCD vat photopolymerization.

Polymer conversion is one of the most important variables in photopolymer additive manufacturing, but it is frequently misunderstood. In practice, it is often treated as if a higher degree of conversion automatically implied a safer or more biocompatible printed part. That interpretation is incomplete.

In vat photopolymerization, final performance and safety are not determined by conversion percentage alone. They depend on the interaction between formulation design, optical exposure, part geometry, cleaning efficiency, post-curing strategy and intended application conditions.

What is polymer conversion?

Polymer conversion, or degree of conversion, describes the fraction of reactive groups in a photopolymer formulation that become incorporated into the cured polymer network during printing and post-curing.

It is usually expressed as a percentage and is frequently used as an indicator of cure quality. However, it should be understood as one system parameter among several, not as a standalone definition of final material safety or suitability.

Why full conversion is not achievable in photopolymer systems

Photopolymerization is inherently limited. Full theoretical conversion is not achieved in practical SLA, DLP and LCD workflows because of several physical and chemical constraints:

light attenuation through the resin and through already cured layers
oxygen inhibition at exposed surfaces
progressive reduction of molecular mobility as the network forms
termination reactions during curing
geometry-dependent internal shadowing and cure heterogeneity

As the network forms, the material becomes less mobile and less able to complete the remaining reactions. For this reason, a cured photopolymer is always a partially converted, multicomponent network, never a chemically complete and uniform solid.

Why conversion is important

Degree of conversion strongly influences:

mechanical stiffness and strength
surface reactivity
dimensional stability
chemical resistance
long-term aging behavior
residual species profile

In general terms, higher conversion tends to reduce the fraction of unreacted or weakly bound species and tends to stabilize the polymer network. But that does not mean that higher conversion alone defines biological response.

Why conversion alone is not enough

Two materials can show similar conversion values and still behave very differently in terms of extractables, leachables, cytotoxicity or regulatory suitability. This happens because the chemical identity of what remains unreacted matters as much as how much remains unreacted.

A moderate conversion level in a better-designed formulation may lead to a safer extractables profile than a higher conversion level in a formulation containing more problematic low-molecular-weight reactive species.

Therefore, conversion must be interpreted together with:

formulation chemistry
residual species composition
post-processing quality
intended use conditions

Commercial evidence: compliance depends on ecosystem control

Publicly available documentation from industrial medical photopolymer systems also supports this interpretation. For example, Formlabs states that full compliance and biocompatibility for BioMed Clear Resin require a dedicated resin tank, build platform and Finish Kit, rather than the resin alone. This is important because it confirms that the validated ecosystem matters, not just the nominal resin identity.

Likewise, recent post-processing studies using BioMed Clear show that cytotoxicity and cell proliferation behavior depend significantly on the chosen post-treatment protocol. This again reinforces that final safety is workflow-dependent.

Conversion, residual species and extractables

The most useful way to understand polymer conversion is to connect it to residual species.

When conversion is incomplete, the printed part may retain:

unreacted monomers and oligomers
photo accelerant fragments
additives such as stabilizers or light blockers
partially reacted low-molecular-weight species

These residual species are the origin of extractables and leachables. Conversion influences their amount, but the final extractables profile also depends on:

whether those species are mobile inside the network
whether they are accessible to washing and post-curing
whether the application environment can extract them

For that reason, conversion must always be linked to the broader chain:

conversion → residual species → extractables/leachables → final exposure risk

Spatial heterogeneity: conversion is not uniform inside a part

Another common simplification is to treat conversion as if it were homogeneous throughout the printed object. In reality, conversion may vary significantly from one region to another.

Lower conversion may appear in:

internal cavities and shadowed zones
thick sections with limited light penetration
optically dense or colored materials
areas receiving less effective post-curing exposure

This means that the most relevant question is often not “What is the average conversion?” but rather “Where are the least converted regions, and what residual species remain there?”

Role of printing parameters

Printing parameters are central because they define the initial formation of the polymer network.

Key variables include:

wavelength and optical output of the printer
irradiance stability over time
layer thickness
exposure time
bottom layer strategy
rest times and overcure margins

3Dresyns’ own process-dependence guidance is correct to emphasize that printer optical output, exposure strategy and part geometry all influence conversion and the resulting extractables/leachables profile.

Role of cleaning, drying and post-curing

Conversion does not stop being relevant once the print is finished. Post-processing is part of the conversion problem.

Cleaning and drying influence the system because:

inefficient washing leaves weakly bound surface residues
dirty or saturated baths reduce extraction efficiency
inadequate drying may trap cleaning fluids or residues before final curing

Post-curing then affects how much of the remaining reactive network can still advance toward the maximum achievable conversion.

In thick, colored or optically dense parts, light post-curing alone may be insufficient. In such cases, thermal post-curing may be required to improve conversion in internal zones.

Conversion and mechanical performance

Mechanical properties are often used as indirect evidence that a part is “well cured,” but this can also be misleading.

Higher conversion often tends to increase:

modulus
hardness
strength

But excessive curing may also increase:

brittleness
internal stress
shrinkage-related distortion

Therefore, the engineering target is not simply “maximum conversion at any cost,” but maximum achievable and application-appropriate conversion under validated conditions.

Conversion and biocompatibility: the critical distinction

This is the most important point.

Biocompatibility is not a direct readout of conversion percentage. A part with higher conversion may still perform poorly if the remaining residual species are chemically problematic or if the application environment promotes their release. Conversely, a material with only moderate conversion may still show acceptable biological response if the formulation is better designed and the workflow is well controlled.

This is why cytotoxicity or ISO-based testing results must be interpreted as workflow-specific outcomes, not intrinsic liquid-resin truths.

3Dresyns’ own testing and IFU documentation correctly frames this: testing data and biocompatibility outcomes are meaningful only under defined reference configurations, and deviations in printer, geometry, cleaning or post-curing may invalidate the interpretation.

Monomer Free (MF) formulation strategy

Monomer Free (MF) systems should be interpreted in this context. Their value is not that they magically remove the need for process validation, but that they are designed to reduce the presence of reactive low-molecular-weight species at the formulation level.

That means MF strategy acts upstream of conversion:

it can improve the starting chemical profile
it can reduce the risk associated with certain residual reactive species
it can support better control of extractables when used under validated workflows

But MF does not eliminate the need for proper printing, cleaning, drying, post-curing and application-specific validation.

System-level interpretation

Critical principle: Polymer conversion is a key engineering variable in photopolymer 3D printing, but it does not define safety, compliance or biocompatibility on its own. These outcomes arise from the complete material–printer–process–post-processing–application system.

Engineering consequences

For real implementation in medical, dental and biomedical workflows, the correct engineering objective is:

to reach the maximum achievable degree of conversion under controlled conditions
to minimize problematic residual species
to reduce extractables and leachables to acceptable levels for the intended use
to validate the full workflow, not just the nominal material

That is a much more rigorous and defensible position than comparing resins by label, price or isolated certification language.

Related technical framework

Governing principle

In vat photopolymerization, polymer conversion defines part of the chemical and mechanical state of the printed network, but not its final safety in isolation. Real performance and biocompatibility depend on the complete workflow and must be interpreted and validated at system level.

From theory to product

The engineering principles described above must be implemented through controlled material selection, validated printing parameters and qualified post-processing workflows.

Explore 3Dresyns® biocompatible material systems designed for workflow-dependent medical, dental and laboratory applications:

For workflow validation, material selection or technical implementation support contact info@3dresyns.com

Biocompatible Photopolymer 3D Printing: System-Level Control of Conversion, Residuals and Extractables